Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 3
2010 1
2011 4
2012 4
2013 1
2014 1
2015 1
2016 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma.
Sheth G, Shah SR, Sengupta P, Jarag T, Chimanwala S, Sairam KVVM, Jain V, Talwar R, Dhanave A, Raviya M, Menon S, Trivedi S, Chitturi TR. Sheth G, et al. Among authors: sairam kvvm. ACS Med Chem Lett. 2022 Dec 13;14(1):41-50. doi: 10.1021/acsmedchemlett.2c00369. eCollection 2023 Jan 12. ACS Med Chem Lett. 2022. PMID: 36655126 Free PMC article.
Long-acting peptidomimetics based DPP-IV inhibitors.
Jadav P, Bahekar R, Shah SR, Patel D, Joharapurkar A, Kshirsagar S, Jain M, Shaikh M, Sairam KV. Jadav P, et al. Among authors: sairam kv. Bioorg Med Chem Lett. 2012 May 15;22(10):3516-21. doi: 10.1016/j.bmcl.2012.03.078. Epub 2012 Mar 28. Bioorg Med Chem Lett. 2012. PMID: 22503246
Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist.
Agarwal S, Patil A, Aware U, Deshmukh P, Darji B, Sasane S, Sairam KV, Priyadarsiny P, Giri P, Patel H, Giri S, Jain M, Desai RC. Agarwal S, et al. Among authors: sairam kv. ACS Med Chem Lett. 2015 Nov 20;7(1):51-5. doi: 10.1021/acsmedchemlett.5b00323. eCollection 2016 Jan 14. ACS Med Chem Lett. 2015. PMID: 26819665 Free PMC article.
Peptidomimetics as potent and selective PTP1B inhibitors.
Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Shah K, Joharapurkar A, Shaikh M, Sairam KV. Patel D, et al. Among authors: sairam kv. Med Chem. 2013 Aug;9(5):660-71. doi: 10.2174/1573406411309050005. Med Chem. 2013. PMID: 23030658
Discovery of inhibitors of plasminogen activator inhibitor-1: structure-activity study of 5-nitro-2-phenoxybenzoic acid derivatives.
Pandya V, Jain M, Chakrabarti G, Soni H, Parmar B, Chaugule B, Patel J, Joshi J, Joshi N, Rath A, Raviya M, Shaikh M, Sairam KV, Patel H, Patel P. Pandya V, et al. Among authors: sairam kv. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5701-6. doi: 10.1016/j.bmcl.2011.08.031. Epub 2011 Aug 11. Bioorg Med Chem Lett. 2011. PMID: 21880486
Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.
Srivastava BK, Soni R, Joharapurkar A, Sairam KV, Patel JZ, Goswami A, Shedage SA, Kar SS, Salunke RP, Gugale SB, Dhawas A, Kadam P, Mishra B, Sadhwani N, Unadkat VB, Mitra P, Jain MR, Patel PR. Srivastava BK, et al. Among authors: sairam kv. Bioorg Med Chem Lett. 2008 Feb 1;18(3):963-8. doi: 10.1016/j.bmcl.2007.12.036. Epub 2007 Dec 23. Bioorg Med Chem Lett. 2008. PMID: 18207393
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification.
Zaware P, Shah SR, Pingali H, Makadia P, Thube B, Pola S, Patel D, Priyadarshini P, Suthar D, Shah M, Jamili J, Sairam KV, Giri S, Patel L, Patel H, Sudani H, Patel H, Jain M, Patel P, Bahekar R. Zaware P, et al. Among authors: sairam kv. Bioorg Med Chem Lett. 2011 Jan 15;21(2):628-32. doi: 10.1016/j.bmcl.2010.12.032. Epub 2010 Dec 10. Bioorg Med Chem Lett. 2011. PMID: 21195611
Synthesis and structure-activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: application of weakly basic sulfoximine group as novel S4 binding element.
Pandya V, Jain M, Chakrabarti G, Soni H, Parmar B, Chaugule B, Patel J, Jarag T, Joshi J, Joshi N, Rath A, Unadkat V, Sharma B, Ajani H, Kumar J, Sairam KV, Patel H, Patel P. Pandya V, et al. Among authors: sairam kv. Eur J Med Chem. 2012 Dec;58:136-52. doi: 10.1016/j.ejmech.2012.10.005. Epub 2012 Oct 16. Eur J Med Chem. 2012. PMID: 23124211
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Darji B, Siriki Y, Bandyopadhyay D, Joharapurkar A, Kshirsagar S, Patel H, Shaikh M, Sairam KV, Patel P. Patel D, et al. Among authors: sairam kv. ChemMedChem. 2011 Jun 6;6(6):1011-6. doi: 10.1002/cmdc.201100077. Epub 2011 Apr 19. ChemMedChem. 2011. PMID: 21506278 No abstract available.
15 results